18F-Fluciclovine-Avid Reactive Axillary Lymph Nodes After COVID-19 Vaccination.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 34183501.
- Also identified by DOI 10.1097/RLU.0000000000003844 and PMC identifier 8745947.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A 74-year-old man presenting with biochemical recurrent prostate cancer 9 months after robotic-assisted radical prostatectomy and pelvic lymphadenectomy underwent 18F-fluciclovine PET/CT for restaging to determine subsequent treatment strategy. Serum prostate-specific antigen was 0.7 ng/mL at the time of imaging. Images demonstrated foci of abnormal increased 18F-fluciclovine uptake corresponding to prominent round lymph nodes in the left axilla, some of which with fatty hila. Due to recent mRNA COVID-19 vaccination in the ipsilateral arm and the low likelihood of nodal metastases to the axilla from prostate cancer in this patient, the lymph nodes were considered to be benign, reactive to the vaccine.
Medical subject headings
- COVID-19
- Prostatic Neoplasms